Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IceCure Medical (ICCM) EPS (Weighted Average and Diluted) (2025 - 2026)

IceCure Medical has reported EPS (Weighted Average and Diluted) over the past 2 years, most recently at $0.06 for Q1 2026.

  • For Q1 2026, EPS (Weighted Average and Diluted) fell 9.02% year-over-year to $0.06; the TTM value through Mar 2026 reached $0.06, down 9.02%, while the annual FY2025 figure was $0.24, 20.0% down from the prior year.
  • EPS (Weighted Average and Diluted) was $0.06 for Q1 2026 at IceCure Medical, down from $0.06 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.06 in Q1 2025 and bottomed at $0.06 in Q1 2026.